LindseyAuroraMD

Cardiology • Detroit, MI

Heart Failure & Transplantation

Advanced Heart Failure and Transplant Cardiologist

Join to view full profile

Dr. Aurora is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Aurora's full profile

Already have an account?

Office
2799 W Grand Blvd

Detroit, MI 48202
Phone+1 313-916-2600

Summary

Dr. Lindsey Aurora completed Internal Medicine residency followed by a Chief Medical Resident year at Henry Ford Hospital (HFH) in Detroit, Michigan. Thereafter, she pursued General Cardiology fellowship at HFH and also served as a Chief Fellow. She completed Advanced Heart Failure and Transplant Fellowship at University of Michigan and re-joined HFH as staff. Dr. Aurora has a strong interest in cardiogenic shock, left ventricular assist devices and inherited cardiomyopathies. She enjoys staying active in research and teaching/working alongside medical trainees!

Education & Training

University of MichiganFellowship, Advanced Heart Failure and Transplant Cardiology, 2022 - 2023
Henry Ford Health/Henry Ford HospitalFellowship, Cardiovascular Disease, 2019 - 2022
Henry Ford Health/Henry Ford HospitalChief Residency, Internal Medicine, 2018 - 2019
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 2015 - 2018
Wayne State University School of MedicineClass of 2015

Certifications & Licensure

MI State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Board of Nuclear CardiologyNuclear Cardiology Certification
ECMO Specialist Training CourseUniversity of Michigan
National Board of EchocardiographyAdult Echocardiography Certification

Awards, Honors, & Recognition

Outstanding Fellow of The Year Nominee Division of Cardiology, Henry Ford Hospital, 2022
Outstanding Service Award, Cardiology Division Division of Cardiology, Henry Ford Hospital, 2021-2022

Clinical Trials

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM Start of enrollment: 2023 Jun 19
Recruiting
Phase 3
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM Start of enrollment: 2023 Aug 30
Recruiting
Phase 3
Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction Start of enrollment: 2023 Dec 20
Recruiting
Phase 2
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure Start of enrollment: 2023 Aug 23
Recruiting
Not Applicable
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure Start of enrollment: 2022 Jun 28
Recruiting
Not Applicable
A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure Start of enrollment: 2023 Dec 12
Recruiting
Phase 2
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM Start of enrollment: 2021 May 06
Enrolling by invitation
Phase 2
Join now to see all

Publications & Presentations

PubMed

Hemodynamic Effects and Clinical Outcomes of Left Atrial Veno-Arterial Extracorporeal Membrane Oxygenation (LAVA-ECMO) in Cardiogenic Shock.
Pedro Arturo Villablanca, Raef Ali Fadel, Gennaro Giustino, Ahmad Jabri, Mir Babar Basir
The American Journal of Cardiology. 2024-11-14
Going With the Flow: Device Therapy for Heart Failure Complicated by Cardiorenal Syndrome.
Lindsey Aurora, Gillian Grafton, Jennifer Cowger
Journal of Cardiac Failure. 2024-11-01
Editorial: Defining the problem, the first step to making progress in acute myocardial infarction and cardiogenic shock care.
Mir Babar Basir, Sarah Gorgis, Lindsey Aurora
Cardiovascular Revascularization Medicine. 2024-07-01

Journal Articles

Going with the flow: device therapy for heart failure complicated by cardiorenal syndrome
Aurora L, Grafton G, Cowger J., J Card Fail. 2024:S1071-9164(24)00066-6
Signaling pathways in hypertrophic cardiomyopathy: will proteomic profiling guide the future?
Aurora L, Wanderley MRB Jr., J Card Fail. 2024;30:473-475.
Defining the problem, the first step to making progress in acute myocardial infarction and cardiogenic shock care.
Basir MB, Gorgis S, Aurora L, Cardiovasc Revasc Med. 2024:S1553-8389(24)00108-8.
Left ventricular restoration for heart failure: putting together the discoveries of prior procedures.
Aurora L, Basir MB, Cowger JA, J Card Fail. 2023;29:1056-1058.
Thinking outside the brain: a rare cause of headaches and confusion.
Aurora L, Bhasin S, Vummidi DR, Heart. 2023;109:1006-1044
Ultrasound-assisted catheter-directed thrombolysis versus anticoagulation alone for management of submassive pulmonary embolism.
Gorgis S, Mawri S, Dabbagh MF, Aurora L, Ali M, Mitchell G, Jacobsen G, Hegab S, Schwartz S, Kelly B, Grafton G, Awdish R, Ismail R, Koenig G, J Cardiol. 2022;80:441-448
COVID-19 risk index (CRI): a simple and validated emergency department risk score that predicts mortality and the need for mechanical ventilation.
Raad M, Gorgis S, Abshire C, Yost M, Dabbagh MF, Chehab O, Aurora L, Patel S, Nona P, Yan J, Singh G, Syrjamaki J, Kaatz S, Parikh S, J Thromb Thrombolysis. 2022;53:567-575.
Prognostic utility of a modified HEART score when different troponin cut-points are used.
Aurora L, McCord J, Nowak R, Giannitsis E, Christenson R, DeFilippi C, Lindahl B, Christ M, Body R, Jacobsen G, Mueller C; TRAPID-AMI Investigators, Crit Pathw Cardiol. 2021;20:134-139
Heart transplant recipients with confirmed 2019 novel coronavirus infection: the Detroit experience.
Al-Darzi W, Aurora L, Michaels A, Cowger J, Grafton G, Selektor Y, Tita C, Hannawi B, Lanfear D, Nemeh HW, Williams CT, Clin Transplant. 2020;34(12):e14091
A pregnant patient with elevated heart rate
Aurora L, Nona P, Ananthasubramaniam K., Am J Med. 2020;134:e313-e314
Suppression tumorigenicity 2 (ST2) turbidimetric immunoassay compared to enzyme-linked immunosorbent assay in predicting survival in heart failure patients with reduce...
Aurora L, Peterson E, Gui H, Zeld N, McCord J, Pinto Y, Cook B, Sabbah HN, Keoki Williams L, Snider J, Lanfear DE, Clin Chim Acta. 2020;510:767-771
Cardiac tamponade secondary to COVID-19
Dabbagh MF, Aurora L, D’Souza P, Weinmann AJ, Bhargava P, Basir MB, JACC Case Rep. 2020;2:1326-1330
Risk prediction in transition: MAGGIC score performance at discharge and incremental utility of natriuretic peptides.
Michaels A, Aurora L, Peterson E, Liu B, Pinto YM, Sabbah HN, Williams K, Lanfear DE, J Card Fail. 2020;26:52-60
Symptoms predictive of acute myocardial infarction in the troponin era: analysis from the TRAPID-AMI Study.
McCord J, Aurora L, Lindahl B, Giannitsis E, Calle-Muller C, Nowak R, Body R, Christ M, deFilippi CR, Christenson RH, Jacobsen G, Alquezar A, Panteghini M, Melki D, Pl..., Crit Pathw Cardiol. 2019;18:10-15
Prognostic utility of the HEART score in the observation unit
Michaels A, Gibbs J, Mawri S, Dirani G, Aurora L, Jacobsen G, Nowak R, McCord J, Crit Pathw Cardiol. 2018;17:179-183
Join now to see all

Books/Book Chapters

Cardiogenic Shock in Acute Myocardial Infarction. In: Katz JN, Brown DL, eds. Cardiac Intensive Care. 4th ed. Elsevier; In Press.
Gorgis S, Aurora L, Basir MB
Type 3 cardiorenal syndrome. In: McCullough PA, Ronco C, eds. Textbook of Cardiorenal Medicine. Cham, Switzerland: Springer; 2021: 95-110.
Soman S, Aurora L
Drugs to avoid in acute decompensated heart failure (ADHF): contraindicated medications and interactions. In: Peacock WF, ed. Short Stay Management of Acute Heart Failure. 3rd ed. New York: Humana Press; 2017: 261-268.
Aurora L, McCord J